×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRL – charles river laboratories international, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
11:02 am
crl
Bioburden Testing Market Analysis Report 2024-2030: Outsourcing Surge Boosts Bioburden Testing Services as CMOs Expand Globally [Yahoo! Finance]
Low
Report
Bioburden Testing Market Analysis Report 2024-2030: Outsourcing Surge Boosts Bioburden Testing Services as CMOs Expand Globally [Yahoo! Finance]
11/18
10:29 am
crl
EW Healthcare Partners Announces Leadership Evolution [Yahoo! Finance]
Low
Report
EW Healthcare Partners Announces Leadership Evolution [Yahoo! Finance]
11/18
08:50 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
11/14
09:34 am
crl
Sterility Testing Market Valuation Set to Worth Over US$ 2,945.74 Million By 2032 | Membrane Filtration Test to Remain the Most Prominent and Highly Preferred Says Astute Analytica [Yahoo! Finance]
Medium
Report
Sterility Testing Market Valuation Set to Worth Over US$ 2,945.74 Million By 2032 | Membrane Filtration Test to Remain the Most Prominent and Highly Preferred Says Astute Analytica [Yahoo! Finance]
11/13
01:14 pm
crl
Insight into Murray Stahl's Strategic Moves: A Focus on Bitcoin Trust and Digital Assets [Yahoo! Finance]
Low
Report
Insight into Murray Stahl's Strategic Moves: A Focus on Bitcoin Trust and Digital Assets [Yahoo! Finance]
11/13
12:31 pm
crl
'Serious risks': Researchers join push against importing monkeys for drug testing [Yahoo! Finance Canada]
Low
Report
'Serious risks': Researchers join push against importing monkeys for drug testing [Yahoo! Finance Canada]
11/12
07:30 am
crl
Bioanalytical Testing Services Market to Surpass USD 9.22 Billion by 2032, Predicted CAGR of 9.4%| Polaris Market Research [Yahoo! Finance]
Low
Report
Bioanalytical Testing Services Market to Surpass USD 9.22 Billion by 2032, Predicted CAGR of 9.4%| Polaris Market Research [Yahoo! Finance]
11/11
11:18 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at TD Cowen from $203.00 to $227.00. They now have a "hold" rating on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at TD Cowen from $203.00 to $227.00. They now have a "hold" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
07:00 am
crl
charles river laboratories international, inc.
BEAT
Report
11.6%
charles river laboratories international, inc.
8/7/2024
07:00 am
crl
charles river laboratories international, inc.
BEAT
Report
-12.6%
charles river laboratories international, inc.
5/9/2024
07:00 am
crl
charles river laboratories international, inc.
BEAT
Report
-3.3%
charles river laboratories international, inc.
2/14/2024
07:00 am
crl
charles river laboratories international, inc.
BEAT
Report
11.4%
charles river laboratories international, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
04:41 pm
crl
Form 4 CHARLES RIVER LABORATORI For: Nov 08 Filed by: FOSTER JAMES C
Medium
Report
Form 4 CHARLES RIVER LABORATORI For: Nov 08 Filed by: FOSTER JAMES C
11/12
04:38 pm
crl
Form 4 CHARLES RIVER LABORATORI For: Nov 06 Filed by: WALLMAN RICHARD F
Medium
Report
Form 4 CHARLES RIVER LABORATORI For: Nov 06 Filed by: WALLMAN RICHARD F
11/8
06:22 pm
crl
Form 4 CHARLES RIVER LABORATORI For: Nov 07 Filed by: Barbo William D
Low
Report
Form 4 CHARLES RIVER LABORATORI For: Nov 07 Filed by: Barbo William D
11/8
05:35 pm
crl
Form SC 13G/A CHARLES RIVER LABORATORI Filed by: BlackRock, Inc.
Low
Report
Form SC 13G/A CHARLES RIVER LABORATORI Filed by: BlackRock, Inc.
11/8
10:53 am
crl
Form SC 13G CHARLES RIVER LABORATORI Filed by: WELLINGTON MANAGEMENT GROUP LLP
Low
Report
Form SC 13G CHARLES RIVER LABORATORI Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/7
04:25 pm
crl
Form 144 CHARLES RIVER LABORATORI Filed by: WALLMAN RICHARD F
Low
Report
Form 144 CHARLES RIVER LABORATORI Filed by: WALLMAN RICHARD F
11/6
09:17 am
crl
Form 10-Q CHARLES RIVER LABORATORI For: Sep 28
Low
Report
Form 10-Q CHARLES RIVER LABORATORI For: Sep 28
11/6
07:22 am
crl
Form 8-K CHARLES RIVER LABORATORI For: Nov 06
Medium
Report
Form 8-K CHARLES RIVER LABORATORI For: Nov 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/11
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2019 Results and Provides 2020 Guidance
11.8%
4/3 Immunologist says he has a possible cure for the coronavirus [FOX News] 8.9%
3/2 Charles River Laboratories Intl. Inc (NYSE: CRL) is now covered by analysts at Deutsche Bank AG. They set a "buy" rating and a $190.00 price target on the stock. 4.3%
3/30 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Wells Fargo & Co from $200.00 to $145.00. They now have an "overweight" rating on the stock. 4.2%
3/4 Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors 4.0%
3/26 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Barclays PLC from $170.00 to $154.00. They now have an "equal weight" rating on the stock. 3.9%
6/19 Laetose(TM), Healthier Sugar Naturally Modified From Table Sugar, Unveiled at Harvard Health Summit 3.5%
3/10 Charles River Laboratories To Participate In Barclays Global Healthcare Conference 3.2%
2/13 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.8%
11/8 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $147.00 to $145.00. They now have a "neutral" rating on the stock. 2.5%
4/3 Immunologist says he has a possible cure for the coronavirus [FOX News] 8.9%
3/2 Charles River Laboratories Intl. Inc (NYSE: CRL) is now covered by analysts at Deutsche Bank AG. They set a "buy" rating and a $190.00 price target on the stock. 4.3%
3/30 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Wells Fargo & Co from $200.00 to $145.00. They now have an "overweight" rating on the stock. 4.2%
3/4 Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors 4.0%
3/26 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Barclays PLC from $170.00 to $154.00. They now have an "equal weight" rating on the stock. 3.9%
6/19 Laetose(TM), Healthier Sugar Naturally Modified From Table Sugar, Unveiled at Harvard Health Summit 3.5%
3/10 Charles River Laboratories To Participate In Barclays Global Healthcare Conference 3.2%
2/13 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.8%
11/8 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $147.00 to $145.00. They now have a "neutral" rating on the stock. 2.5%
TOP News Decliners
3/19
Doctor says he's 3-4 weeks from developing treatment to 'neutralize' coronavirus [FOX News]
-18.6%
4/21 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. They now have a $139.00 price target on the stock. -6.4%
5/7 Q1/2019 3/30/2019 EPS 1.400 ZacksConsensus 1.380 ActVsEst 0.020 - Beat -5.7%
3/4 Form 3 CHARLES RIVER LABORATORI For: Mar 02 Filed by: Andrews Nancy C -4.9%
7/31 Q2/2019 6/29/2019 EPS 1.630 ZacksConsensus 1.550 ActVsEst 0.080 - Beat -4.5%
10/21 Charles River Laboratories Announces Offering of $500 Million of Senior Notes -4.4%
3/17 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at SunTrust Banks, Inc. from $188.00 to $124.00. They now have a "buy" rating on the stock. -4.0%
9/9 Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio -3.7%
10/1 Charles River Laboratories Adds Virginia M. Wilson to Board of Directors -3.2%
3/27 Charles River Laboratories Intl. Inc (NYSE: CRL) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $152.00 price target on the stock. -2.9%
4/21 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. They now have a $139.00 price target on the stock. -6.4%
5/7 Q1/2019 3/30/2019 EPS 1.400 ZacksConsensus 1.380 ActVsEst 0.020 - Beat -5.7%
3/4 Form 3 CHARLES RIVER LABORATORI For: Mar 02 Filed by: Andrews Nancy C -4.9%
7/31 Q2/2019 6/29/2019 EPS 1.630 ZacksConsensus 1.550 ActVsEst 0.080 - Beat -4.5%
10/21 Charles River Laboratories Announces Offering of $500 Million of Senior Notes -4.4%
3/17 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at SunTrust Banks, Inc. from $188.00 to $124.00. They now have a "buy" rating on the stock. -4.0%
9/9 Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio -3.7%
10/1 Charles River Laboratories Adds Virginia M. Wilson to Board of Directors -3.2%
3/27 Charles River Laboratories Intl. Inc (NYSE: CRL) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $152.00 price target on the stock. -2.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: